We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.3B
AUM Growth
+$580M
(+2.8%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
882
New
52
Increased
484
Reduced
289
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGD
New Gold Inc
NGD
|
+$52.1M |
| 2 |
Veeva Systems
VEEV
|
+$37.6M |
| 3 |
UnitedHealth
UNH
|
+$36.1M |
| 4 |
ServiceNow
NOW
|
+$35.9M |
| 5 |
B
Barrick Mining
B
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$43.4M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
+$38.4M |
| 3 |
Walt Disney
DIS
|
+$35.1M |
| 4 |
McKesson
MCK
|
+$34.8M |
| 5 |
Hershey
HSY
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 56.36% |
| 2 | Technology | 9.22% |
| 3 | Energy | 7.08% |
| 4 | Healthcare | 5.95% |
| 5 | Financials | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Eli Lilly
LLY
$1.07T
| $12.3M | 0.06% |
110,159
-5,728
| -5% | -$638K |
|
|
AVTR.PRA
202
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $12.1M | 0.06% |
226,039
+19,037
| +9% | +$1.14M |
|
203
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.1M | 0.06% |
179,194
-3,534
| -2% | -$272K |
|
204
Nabors Industries
NBR
$1.16B
| $11.8M | 0.06% |
126,593
-54,159
| -30% | -$6.09M |
|
205
The Mosaic Company
MOS
$7.1B
| $11.8M | 0.06% |
575,146
-37,932
| -6% | -$826K |
|
206
Qorvo
QRVO
$7.92B
| $11.7M | 0.06% |
158,287
+17,362
| +12% | +$1.26M |
|
207
Goldgroup Mining Inc.
GORO
$162M
| $11.5M | 0.05% |
3,763,270
+158,675
| +4% | +$556K |
|
208
Walmart Inc
WMT
$889B
| $11.5M | 0.05% |
289,572
-4,803
| -2% | -$181K |
|
209
Toro Company
TTC
$9.01B
| $11.5M | 0.05% |
156,250
-927
| -0.6% | -$66.2K |
|
|
GSS
210
DELISTED
Golden Star Resources Ltd.
GSS
| $11.4M | 0.05% |
4,000,542
-1,781,449
| -31% | -$6.21M |
|
|
CNP.PRB
211
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
| $11.2M | 0.05% |
213,482
+17,982
| +9% | +$914K |
|
212
Hercules Capital
HTGC
$2.95B
| $11.1M | 0.05% |
829,225
+5,870
| +0.7% | +$76.6K |
|
213
Qiagen
QGEN
$8.47B
| $11M | 0.05% |
315,781
-18,262
| -5% | -$702K |
|
|
GSV
214
DELISTED
Gold Standard Ventures Corp.
GSV
| $11M | 0.05% |
14,299,644
+2,288,582
| +19% | +$2.22M |
|
215
iShares Core US Aggregate Bond ETF
AGG
$138B
| $10.4M | 0.05% |
91,861
-24,225
| -21% | -$2.72M |
|
216
Vanguard Total Bond Market
BND
$158B
| $10.4M | 0.05% |
123,109
-32,753
| -21% | -$2.75M |
|
217
Tencent Music
TME
$15.3B
| $10.4M | 0.05% |
810,800
+434,000
| +115% | +$6.11M |
|
218
Sixth Street Specialty
TSLX
$1.63B
| $10.1M | 0.05% |
482,506
+36,642
| +8% | +$744K |
|
|
CJ
219
DELISTED
C&J Energy Services, Inc.
CJ
| $10.1M | 0.05% |
937,007
-204,146
| -18% | -$2.12M |
|
220
Charles River Laboratories
CRL
$10.8B
| $9.93M | 0.05% |
74,976
+1,814
| +2% | +$243K |
|
|
AEPPL
221
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $9.68M | 0.05% |
175,811
+14,810
| +9% | +$822K |
|
222
Blackstone Mortgage Trust
BXMT
$2.8B
| $9.59M | 0.04% |
267,384
+18,195
| +7% | +$647K |
|
|
CIM
223
Chimera Investment
CIM
$1.05B
| $9.56M | 0.04% |
162,964
+3,782
| +2% | +$220K |
|
|
TWO
224
Two Harbors Investment
TWO
$1.27B
| $9.4M | 0.04% |
179,018
-1,494
| -0.8% | -$78.8K |
|
225
Neurocrine Biosciences
NBIX
$17.7B
| $9.35M | 0.04% |
103,752
+1,469
| +1% | +$137K |
|
Similar funds
DAM
VanEck Associates's Q3 2019 Portfolio in Review
As of Q3 2019, VanEck Associates held 882 positions worth $21.3B, up 2.8% from $20.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
VanEck Associates's Q3 2019 filing shows 52 new, 484 increased, 289 reduced and 51 closed positions. Its largest new stake was Veeva Systems: 234,351 shares worth $35.8M. The largest sale was Allergan plc, an estimated $43.4M.
By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 55% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2019 buy was Veeva Systems: 234,351 shares worth $35.8M.
- VanEck Associates added most to New Gold Inc in Q3 2019, an estimated $52.1M increase.
- VanEck Associates's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $43.4M.
- VanEck Associates fully exited Ensco Rowan plc in Q3 2019, selling an estimated $38.4M.
- VanEck Associates's ten largest holdings make up 36% of its $21.3B portfolio in Q3 2019.
- VanEck Associates opened 52 new positions and closed 51 in Q3 2019.
- VanEck Associates's portfolio value rose 2.8% quarter-over-quarter to $21.3B.
Based on VanEck Associates's 13F filing for Q3 2019, filed 8 Nov 2019.